Ideal Power Appoints David Somo as President and Chief Executive Officer

Stock Information for Karyopharm Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Karyopharm Therapeutics Inc.

Ideal Power Reports Third Quarter 2025 Financial Results
Ideal Power to Host Third Quarter 2025 Results Conference Call on November 13, 2025 at 10:00 AM Eastern Time
Ideal Power Announces Power Rating Increase for its Discrete B-TRAN® Product
Ideal Power to Present at H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025
Ideal Power Reports Second Quarter 2025 Financial Results
Ideal Power to Host Second Quarter 2025 Results Conference Call on August 14, 2025 at 10:00 AM Eastern Time
Ideal Power Secures Order from a Fifth Global Tier 1 Automotive Supplier
Ideal Power Announces Collaboration with Fourth Global Tier 1 Automotive Supplier

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.